A new company has emerged, offering innovative solutions across life sciences and diagnostics to improve lives everywhere. Revvity, Inc. has officially launched as a science-based solutions company that leverages innovation to deliver end-to-end expertise and solutions from research discovery to development, diagnosis, and cure.
The company was previously affiliated with PerkinElmer, Inc. and is poised to make a difference in the lives of people everywhere. Prahlad Singh, President and CEO of Revvity, said, “At Revvity, we are united with our customers to impact health across the lifespan. Our purpose is to expand the boundaries of human potential through science.”
Revvity provides reagents, consumables, assays, instruments, and software to customers in various markets, including pharma and biotech, diagnostic labs, academia, and government agencies. Singh stated, “We’re a translational company in the sense that our capabilities facilitate decision making between research and clinical customers. With cross-business collaborations between our automation, multi-omics offerings, and our Signals software business, we have unique capabilities which put us in an optimal position to accelerate breakthrough solutions – starting with preclinical research and scientific discovery, all the way through to diagnosing and helping to treat disease.”
The company’s goal is to expand the boundaries of human potential through science and impactful solutions. Revvity is committed to delivering innovative solutions that can improve lives everywhere. With its comprehensive offerings and expertise, Revvity is poised to be a leader in the life sciences and diagnostics industry.
